Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours

Fleischmann, Achim; Rotzer, Diana; Seiler, Roland; Studer, Urs E; Thalmann, George N (2011). Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. European urology, 60(2), pp. 350-7. Amsterdam: Elsevier 10.1016/j.eururo.2011.05.035

Full text not available from this repository. (Request a copy)

Her2, an alias for the protein of v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian), might be an attractive therapeutic target in metastasising bladder cancer. Genotype and phenotype of primary tumours and their metastases may differ.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Fleischmann, Achim; Rotzer, Diana; Seiler, Roland; Studer, Urs and Thalmann, George

ISSN:

0302-2838

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:18

Last Modified:

06 Dec 2013 13:25

Publisher DOI:

10.1016/j.eururo.2011.05.035

PubMed ID:

21640482

Web of Science ID:

000291977400034

URI:

https://boris.unibe.ch/id/eprint/5479 (FactScience: 210226)

Actions (login required)

Edit item Edit item
Provide Feedback